Cardiovascular Medicine


Showing 211-220 of 248 Results

  • Mirela Tuzovic, MD

    Mirela Tuzovic, MD

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Mirela Tuzovic is a board-certified, fellowship-trained cardiologist and medical director of the Stanford Health Care Center for Marfan Syndrome and Related Aortic Disorders. Dr. Tuzovic is also a clinical assistant professor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.

    Dr. Tuzovic diagnoses and treats a wide range of cardiovascular conditions, including aortic disorders, Marfan syndrome and other heritable thoracic aortic disorders, and cardiovascular disease. She also specializes in cardiovascular imaging and structural echocardiology. For each of her patients, she offers a comprehensive, personalized care plan.

    Dr. Tuzovic’s research interests include the diagnosis and management of patients with aortic disease as well as cardiovascular imaging. As a structural echocardiographer, she is involved in multiple clinical trials for transcatheter valve repair and replacement through the Stanford Health Care Structural Heart Program. Her prior research focus has included echocardiography and cardio-oncology.

    Dr. Tuzovic has published her research in peer-reviewed journals such as Circulation, the American Journal of Cardiology, Echocardiography, and JACC: CardioOncology.

    Dr. Tuzovic is a member of the American College of Cardiology, the American Society of Echocardiography, and the Montalcino Aortic Consortium.

  • Randall Vagelos, MD

    Randall Vagelos, MD

    Professor of Medicine (Cardiovascular)

    Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
    IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions.

  • Hannah Valantine

    Hannah Valantine

    Emeritus Faculty-Univ Med Line, Medicine - Cardiovascular Medicine

    Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.

  • Anubodh Sunny Varshney

    Anubodh Sunny Varshney

    Clinical Assistant Professor, Medicine - Cardiovascular Medicine

    BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor, Medical Director of Mechanical Circulatory Support, and Associate Director of the Fellowship Program in the Section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also a clinical researcher and works to identify patient groups that have sub-optimal outcomes with current therapies, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence adoption of novel drug and device therapies for cardiovascular disease.

    Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.

    Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke.